Literature DB >> 12544671

Amended report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy.

.   

Abstract

Mesh：

Year:  2003        PMID： 12544671

Source DB:  PubMed          Journal:  Menopause        ISSN： 1072-3714            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease. Recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors:  B L Abramson
Journal:  CMAJ       Date:  2004-04-27       Impact factor: 8.262

Review 2.  The Women's Health Initiative study: perspectives and implications for clinical practice.

Authors:  Charles B Hammond
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

3.  Brief report: attitudes toward hormone therapy after the Women's Health Initiative: a comparison of internists and gynecologists.

Authors:  Allan S Brett; Patricia I Carney; Robert E McKeown
Journal:  J Gen Intern Med       Date:  2005-05       Impact factor: 5.128

Review 4.  Changes in postmenopausal hormone therapy use since 1988.

Authors:  Jung Ki Kim; Dawn Alley; Peifeng Hu; Arun Karlamangla; Teresa Seeman; Eileen M Crimmins
Journal:  Womens Health Issues       Date:  2007-10-22

5.  Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.

Authors:  Ditte-Marie Bretler; Peter Riis Hansen; Steen Zabell Abildstrøm; Casper Haslund Jørgensen; Rikke Sørensen; Morten Lock Hansen; Tina Ken Schramm; Ellen Løkkegaard; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

6.  Combined hormone therapy at menopause and breast cancer: a warning--short-term use increases risk.

Authors:  Leslie Bernstein
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

7.  Perimenopausal and Postmenopausal Health.

Authors:  Angela M Cheung; Ruhee Chaudhry; Moira Kapral; Cynthia Jackevicius; Gail Robinson
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.